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Abstract The process of CaZ+-induced Ca 2+ release (CICR) was 
studied in saponin permeabilised human myometrial smooth mus- 
cle cells in which the sarcoplasmic reticulum (SR) was pre-loaded 
with 45Ca 2+. A rise in the free Ca 2+ concentration of the bathing 
solution from 100 nM tot 10 ~M increased the rate of 4~Ca2+ 
loss, while a reduction to 10 nM decreased the rate of 4SCa2+ lOSS. 
Ruthenium red (20/~M) lowered the basal rate of 45Ca2+ lOSS and 
reduced CICR. Caffeine did not activate 4SCa2+ release although 
ryanodine induced 4SCa2+ release and CICR was augmented in the 
presence of caffeine. These data suggest he operation of a Ca 2+- 
activated 45Ca2÷ release process which is similar in many of its 
properties to the CICR process described in many cells. The basic 
properties of the CICR mechanism in myometrium differs in 
many respects from the CICR process recently described in 
human vascular smooth muscle. 
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I. Introduction 
In myometrial smooth muscle, a rise in intracellular Ca a+ as 
a result of a Ca '-+ influx across the surface membrane, via 
voltage or receptor-operated ion channels, can activate a fur- 
ther increase in cytoplasmic Ca -'+ as a result of Ca 2+ release 
from intracellular stores [l,(review)]. The total change in cyto- 
plasmic Ca 2+ is subseqently responsible for activating contrac- 
tion in smooth muscle. In many cells, the internal mechanisms 
responsible for these events include an inositol trisphosphate 
(IPs)-sensitive r ceptor/channel complex and a ryanodine-sen- 
sitive Ca>-induced Ca -'+ release (R-CICR) mechanism [2-5]. 
Many cell types have been shown to express both of these 
mechanisms [2], however, the precise role of each system and 
the possible interaction between the two mechanisms remains 
unclear. 
In cultured myometrial smooth muscle cells, agonists, such 
as oxytocin, can activate repetitive oscillations in intracellular 
Ca -'+ in the absence of external Ca -'+ [6]. These oscillations are 
due to the receptor activated production of 1P3 which leads to 
the release of Ca 2+ from an IP3-sensitive intracellular store [1]. 
Oxytocin-dependent increases in the production of IP3 have 
been reported in intact myometrial smooth muscle cells [7] and 
recently il has been shown that 1P3 induces a dose-dependent 
release of 4>Ca -'+ in permeabilised myometrial cells [8]. R-CICR 
was not thought to be present in the myometrium since caffeine, 
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a widely used activator of R-CICR, was unable to release Ca -` + 
from an internal store and so did not promote contractions in
pregnant rat uterus [9] or mobilise Ca -` + from the intracellular 
stores of single cultured human cells [6]. The effects of caffeine 
are almost certainly complicated as a result of its known 
phosphodiesterase activity which leads to an elevation of 
cAMP and subsequent relaxation of the muscle [9]. Inhibitory 
actions of caffeine have also been reported on the IP~ receptor, 
where caffeine may block the receptor itself [10] or inhibit the 
production of IP~ [11]. However, ryanodine was able to mobil- 
ise intracellular Ca `-+ in intact cultured myometrial smooth 
muscle cells, suggesting that a caffeine-insensitive, ryanodine- 
sensitive Ca ~ release mechanism ay be functional in these 
cells [12]. 
Three structurally distinct forms of the ryanodine binding 
Ca 2+ release channel complex have been identified, RyR1, 
RyR2 and RyR3 [13]. RyRI is found predominantly in skeletal 
muscle and is closely associated with a dihydropyridine (DHP) 
receptor protein [14]. The RyR1 complex is thought o operate 
as the voltage sensor of the t-tubular membrane where depo- 
larisation of the t-tubular membrane l ads to the release of Ca > 
from the sarcoplasmic reticulum (SR). The RyR2 system, found 
in cardiac muscle, appears to be exclusively activated by cyto- 
plasmic Ca > derived as a result of Ca > influx from the external 
environment Both RyRI and RyR2 are known to be modu- 
lated by caffeine and calmodulin and are sensitive to Ca -'+, Mg 2+ 
and ATP [13,15]. A third isoform of the ryanodine receptor/ 
channel complex (RyR3) has been identified in rabbit brain and 
vascular smooth muscle [16] and in mink lung epithelial cells 
[17]. The function of RyR3 and its specific sensitivity to Ca -~, 
ryanodine and other agents are not known. However, it has 
been reported that the RyR3 isoform in mink lung is not acti- 
vated by caffeine. The mRNAs encoding l\~r RyRI and RyR3 
have been detected in human myometrial smooth muscle [18] 
but the details concerning the contribution of these differen! 
isoforms to intracellular Ca -~ release are not known. 
CICR has been described previously in various types o[" 
chemically skinned smooth muscle using caffeine [2,19]. Re- 
cently, we have reported the presence of a caffeine-insensitive 
R-CICR mechanism in human vascular smooth muscle cells 
[20]. The data obtained in the present experiments confirm the 
presence of a ryanodine-sensitive CICR process in human 
myometrial smooth muscle cells which demonstrates profound 
difl'erences in sensitivity to ryanodine, caffeine and ruthenium 
red compared to the mechanism described in vascular smooth 
muscle. This paper attempts to highlight hese differences and 
suggests the possible contribution of this Ca-'+-mobilising 
mechanism lo the overall Ca>-signalling processes m human 
myometrial smooth muscle cells. Part of this work has been 
published in abstract form [18]. 
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2. Materials and methods 
2.1. Tissue preparation and culture techniques 
Myometrial tissue was taken from the lower uterine segment, with 
informed consent, from patients undergoing either hysterectomy 
(women under 40 years of age) or elective caesarean section. Ethical 
approval was obtained from Newcastle Area Health Authority. My- 
ocytes were prepared using a dispase/collagenase digestion [21] and 
maintained in M199 (Gibco Ltd) supplemented with 10% FCS, 1% 
glutamine and 2% penicillin/streptomycin. Cells were grown to conflu- 
ence in culture flasks before being passaged onto plastic 12-well multi- 
wells for 45Ca2+ efflux studies. Cells were not used beyond passage 
number 6. Immunofluorescent staining for ~-actin was carried out 
routinely on cultured cells to check the purity of preparations. 
2.2. 45 Cd+ efflux from saponin-permeabilised cultured cells 
Confluent cells, grown in 12-well multiwells, were washed with a 
balanced salt solution containing (mM); 135 NaC1, 5.9 KCI, 1.5 CaC12, 
1.2 MgCl2, 11.6 HEPES and 11.5 o-glucose, pH 7.3, to remove the 
culture medium, before being fixed to a mechanical shaker. Cells were 
permeabilised at 25°C with 15 pg/ml saponin for 15 min in the following 
skinning solution (mM): 120 KCI, 10 HEPES, 2 MgClz, 1 ATP and 1 
EGTA, pH 7.0. The efficiency of skinning was routinely checked using 
trypan blue staining. This permeabilisation technique has been shown 
to leave the SR functionally intact [19]. It has also been reported that 
the use of a cultured monolayer of cells in 45Ca2+ efflux studies is 
advantageous since the problem of saponin penetration into tissue 
strips is overcome, allowing all cells to be skinned simultaneously for 
the minimum length of time. 45Ca2+ exchange into the extracellular 
space is also minimised under these conditions [22]. 
Traces of saponin were removed by washing the cells with a loading 
buffer containing (mM): 120 KCI, 10 HEPES, 5 MgCI2, 5 ATP, 0.44 
EGTA, 5 NaN 3 and 0.12 CaC12, pH 6.89. The mitochondrial Ca 2÷ 
ATPase inhibitor NaN 3 was used to eliminate any contribution of Ca 2÷ 
released from mitochondrial pools to the overall efflux of Ca 2+. Non- 
mitochondrial intracellular stores were passively loaded with 10,uCi of 
45Ca2+ per well for 15 min in 0.5 ml of the loading buffer. Loading was 
terminated by washing, at least 3 times, with ice-cold loading buffer 
prior to the start of efflux. The efflux buffer contained (mM): 120 KC1, 
10 HEPES, 1 ATP, 3 EGTA and 5 NaN 3. The amount of CaCI: and 
MgCI2 required to give solutions of known free Ca 2+ concentration was 
calculated using the program REACT [23] and resting Ca 2÷, in control 
conditions, was taken to be 100 nM. Unless otherwise stated, paired 
experiments were carried out where 6 wells per multiwell were used as 
internal controls. 45Ca2+ in the efflux medium was monitored as 2-min 
time intervals and the remaining 45Ca 2+ in the cells at the end of efflux 
was determined by solubilising the cells with 2% SDS. All experiments 
were carried out at room temperature (25°C) and the efflux of radiola- 
belled Ca 2+ was determined by liquid scintillation counting. The loss of 
45Ca2+ at each time period (i.e. fractional loss) was calculated from the 
cpm as a fraction of the total 45Ca2+ remaining (including the final SDS 
fraction) within the cells at that time point. 
Data are expressed as mean + S.E.M. Where appropriate, date were 
analysed using paired t tests and P value of < 0.05 was considered 
significant. 
3. Results 
3.1. Ca:+-dependent 45Cae+ release in permeabilised cultured 
cells 
Since the physiological stimulus for C ICR is, by definition, 
Ca z+, the effect of changing the free Ca 2. concentrat ion i a step 
wise manner  through the range 10 nM to l0/.tM was measured 
on 45Ca2+ efflux in permeabil ised myometrial  smooth muscle 
cells. The basal level of Ca 2+ was taken to be 100 nM since this 
is considered to be close to the resting free Ca 2+ concentrat ion 
measured in intact cells. The basal efflux of 45Ca2+ reached a 
steady state within approximately l0 min after which the con- 
centrat ion of Ca 2+ in the bathing medium was stepped through 
the range 10 nM to 10 pM Ca 2÷ (Fig. 1A, indicated by bars). 
The release of 45Ca 2+ reached a peak after 4 min, declining 
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Fig. 1. Demonstration of a Ca2+-dependent 45Ca2+ release process in 
saponin-permeabilised human myometrial smooth muscle cells. A: data 
from a single experiment (1 of 8) where the concentration f free Ca 2+ 
in the bathing solution was changed from 100 nM to 10 nM (IlL 100 
nM (*) 300 nM (e), 1 pM (X) and 10 pM (+) at the point indicated 
by the bar. B: mean data _+ S.E. from 8 experiments a illustrated in Fig. 
5A, where results have been plotted to show the amount of 45Ca2+ loss 
at each free Ca 2+ concentration during the entire period of the step. 
Data are expressed relative to the loss measured in 100 nM Ca 2+. The 
open symbols ([]) and dotted line represents data from a single experi- 
ment where the Ca 2÷ concentration range was extended to 50 and 100 
,uM. Ordinates how fractional loss of 45Ca 2+ and mean change in 45Ca2+ 
loss, respectively, the abscissae denote time in minutes. Temperature of
all experiments, 22-24°C. 
slowly over the course of the experiment. Although the re- 
sponses were not sustained, the efflux at all Ca 2+ concentrat ions 
did not reach baseline values even after 8 min in the respective 
Ca 2+ buffers. Incubat ion of ceils in 10 nM Ca 2+ (g) caused a 
decrease in the fractional oss of 45Ca2+ suggesting that this 
Ca2+-dependent 45Ca2+ release mechanism ay be functional at 
resting levels of Ca 2+ in the cell. Data analysed from 8 experi- 
ments is i l lustrated in Fig. 1B where the mean change in frac- 
tional loss of 45Ca 2+ released is plotted against he Ca 2+ concen- 
trat ion of the bathing solution and shows a Ca2+-dependent 
activation of 45Ca 2+ loss from the SR in response to the Ca 2+ 
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Fig. 2. The effect of ruthenium red o n  4 5 C a 2 +  efflux. A: summarises data 
from a total of 7 experiments (means +_ S.E.), illustrating the blocking 
action of ruthenium red on Ca:+-induced 4SCa> release. ( l) shows 
control CICR data and ($) shows CICR data in presence of 20/aM 
ruthenium red. Data was analysed using a Student's paired t test and 
there is a significant reduction at all Ca :+ concentrations, except 10 nM. 
B: mean data illustrating the efflux of 4SCa2+ in (A) 100 nM Ca > 
control, (B) 100 nM Ca > in the presence of ruthenium red, (C) 10 nM 
Ca > control and (D) 10 nM Ca > in the presence of ruthenium red. (B), 
(C), and (DI are significantly different to (A) where P<0.05. Ordinates 
show mean change in 45Ca> loss. the abscissa denotes Ca > concentra- 
tion in/aM. Temperature of all experiments 22 24°C. 
step. Data from a single experiment is shown by the open 
symbols and dotted line and suggest hat, at Ca 2+ concentra- 
tions >10/aM, the Ca2+-induced 45Ca2+ release mechanism ay 
decrease. This type of Ca 2+ step experiment has recently been 
described in human vascular smooth muscle from the uterine 
artery [20] where an inhibitory action of Ca =+ on the C ICR 
channel has been suggested at Ca =+ concentrations >10 UM. 
3.2 Inhibition of Ca :+ induced 45Ca2+ release by ruthenium red 
Ruthenium red is routinely used to block the CICR channel 
on the SR [24] and Fig. 2 shows data accumulated from 7 paired 
experiments where cells were incubated in 20#M ruthenium red 
for 10 min prior to the Ca 2+ step. In the concentration range 
100 300 nM Ca >, ruthenium red completely blocked the CICR 
response, however, there was only 50% inhibition of 4SCae+ 
release at Ca > concentrations >300 nM (Fig. 2A). Data illus- 
trating the effect of ruthenium red on basal 45Ca> efflux is 
shown in Fig. 2B where column A and B represents the mean 
control efflux in 100 nM Ca -'+ and the effecl of ruthenium red 
on the 100 nM Ca =+ efflux, respectively. The results show a 
significant reduction in basal el'flux in the presence of ruthe- 
nium red, however, the decrease is not significantly difl'erent 
from the level attained after exposure to 10 nM Ca > under 
control conditions (column C) or in 10 nM Ca 2+ in the presence 
o1" ruthenium red (column D). This effect of ruthenium red on 
basal Ca > supports the idea that CICR is operating at resting 
cytoplasmic levels of Ca > in myometrial cells. 
3.3. Modulation of CICR by eqffehn, 
In intact cultured human myometrial cells, caffeine is unable 
to induce Ca > release [15]. Similarly, when caffeine is applied 
as a 2-rain pulse in permeabilised cells, there is no change in the 
fractional loss of 45Ca2+ [8]. However, Fig. 3 illustrates data 
from 5 paired experiments where prolonged incubation of per- 
meabilised cells with 10 mM caffeine, for up to 16 min, caused 
a small but significant increase in the overall basal efftux of 
45Ca>, from a control fractional loss of 0.1052+0.003 to 
0.1 176 +_ 0.003 in the presence of caffeine (Fig. 3A). Fig. 3B 
illustrates the effect of a prolonged incubation with caffeine on 
the response of cells to the Ca > step. There is a small but 
significant increase in the magnitude of Ca>-induced aSca> 
release over the entire range of Ca > concentrations used. Cat L 
feine appeared to have no effect on the time course of the 
response (data not shown). 
3.4. EJ, lbct ~?/ ryanodine and caffeine on 4SCa -> release 
We have previously shown that ryanodine can induce a dose- 
dependent a~Ca =+ release from the intracellular stores of perme- 
abilised myometrial cells [8,18]. Fig. 4A shows mean data from 
9 experiments illustrating the dose response curve to ryanodine. 
The curve is complex and demonstrates two bell-shaped curves 
over the ryanodine concentration range 0.1 100/aM. Fig. 4B 
demonstrates that this ryanodine-induced 45Ca-'+ release is sen- 
sitive to ruthenium red where column A shows a control re- 
sponse to 1/*M ryanodine and column B illustrates the effect 
of 20 /aM ruthenium red on the I /aM ryanodine response. 
Column C shows that heparin (2(1/ag/mll does not affect the 
response to ryanodine. 
Caffeine alone does not induce a marked release of Ca =~ in 
intact myometrial cells. However, the present data show that 
it can modulate the response to ryanodine and Fig. 4C shows 
a typical experiment (1 of 5 paired experiments) illustrating the 
effect of caffeine on the ryanodine dose-response curve where 
caffeine causes an augmentation of the ryanodine induced 
45Ca> release at particularly in the ryanodine concentration 
range 1 -30 pM. 
4. D iscuss ion  
The present data demonstrate the presence a Ca:+-induced 
45Ca2+ release mechanism in permeabilised, cultured myomet- 
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Fig. 3. The effect of caffeine on Ca2+-induced 4 5 C a 2 +  release. A: a 
histogram showing mean data from 5 paired experiments illustrating 
the effect of 10 mM caffeine on the basal flux (100 nM Ca 2+) prior to 
the step. There is a small but significant increase in basal flux in the 
presence of caffeine where P < 0.05. B: mean data _+ S.E. from 5 exper- 
iments illustrating the effect of caffeine on CICR over the range 
10 nM-10/.zM. The increase issignificant (P < 0.05) at all Ca ~+ concen- 
trations hown. Ordinates how the mean change in fractional loss of 
45Ca2+ and the abscissa denotes the concentration f Ca 2÷ in ¢tM. Tem- 
perature of all experiments 22 24°C. 
rial smooth muscle cells. Using a similar technique of 45Ca2+ 
efflux, CICR has been demonstrated directly in skinned rabbit 
arterial smooth muscle [25]. The Ca 2+ concentrations u ed in 
this study are similar to those used in other saponin-skinned 
preparations where Ca 2÷ release from the SR could be facili- 
tated by Ca 2÷ itself when the bathing concentration of Ca 2+ 
exceeded 300 nM [20,25,26]. The Ca2+-induced 45Ca2+ release 
mechanism in myometrial cells has many properties of a CICR 
process mediated by a ryanodine receptor but appears to be 
different in several respects to the ryanodine-sensitive CICR 
mechanisms reported in cardiac and skeletal muscle [13,15,27]. 
In one respect, caffeine has little direct Ca2+-mobilising effect, 
however, it has been shown to enhance ryanodine-induced 
45Ca2+ mobilisation in these cells and it may also modulate 
R-CICR after prolonged incubation. The lack of a direct stim- 
ulatory action of caffeine is in agreement with data reported on 
pregnant rat uterus [9] and in intact human myometrial cells 
using optical techniques to monitor intracellular Ca 2+ [6,20]. 
The effects of caffeine are almost certainly complicated as a 
result of its known phosphodiesterase activity which leads to 
an elevation of cAMP and subsequent relaxation of the muscle 
[9] as well as its reported effects on IP~ production and IP 3 
binding to its receptor [10,11]. 
However, the small but significant increase in R-CICR seen 
after prolonged incubation with caffeine may reflect a differen- 
tial effect of caffeine on one of the isoforms present in these 
cells. Two isoforms of the ryanodine receptor/channel complex, 
RyR1 and RyR3, have been previously identified in myometrial 
smooth muscle tissue and cultured cells [18]. Additionally, pre- 
liminary data using quantitative t chniques to assess the rela- 
tive amounts of each isoform in myometrial tissue indicates that 
the RyR3 isoform is predominant with RyR1 present only in 
small amounts (unpublished observations). Since the RyR3 
isoform is reported to be caffeine insensitive [17], it is possible 
that the small effect of caffeine on the C1CR response may be 
due to its effect on RyRI since, in skeletal muscle, this isoform 
is known to be caffeine sensitive [15]. However, further studies 
are required in order to fully characterise the contribution of 
each isoform to the overall mobilisation of Ca 2+ in these cells. 
Our data show that a reduction in the free Ca 2+ concentra- 
tion of the bathing medium from a basal level of 100 nM to 
10 nM leads to a reduction in R-CICR suggesting that a compo- 
nent of the R-CICR system appears to be active at Ca 2+ concen- 
trations similar to those found in the resting cell. This may 
indicate that R-CICR is involved in the determination of the 
basal level of Ca z÷ in the cytoplasm. A similar mechanism has 
recently been described in human vascular smooth muscle [20] 
and differs from other smooth muscle types where CICR seems 
to be inoperative at cytoplasmic levels of Ca 2+ [3]. At free Ca `,+ 
concentrations > 10 ¢tM, R-CICR is reduced indicating that the 
process may inactivate at high free Ca 2+ levels. The biphasic 
actions of Ca 2+ suggested from these results are similar to the 
activation and inactivation of the CICR mechanisms described 
in skeletal and cardiac tissue [15]. The Ca 2+ sensitivity of this 
mechanism suggests that it could operate as a Ca2+-dependent 
Ca 2+ leak. If Ca 2÷ in the cytoplasm were to rise, this leak would 
increase, leading to a further rise in cytoplasmic Ca 2+. 
The possibility that the Ca2+-induced 45Ca2+ release observed 
in these cells is a direct result of the driving force for Ca 2+, i.e., 
Ca 2+ Ca 2÷ exchange across the SR must be considered. How- 
ever, since the R-CICR response issensitive to ruthenium red and 
modulated by other factors such as caffeine this possibility 
seems unlikely. 
Ruthenium red was used in this study to characterise the 
nature of the R-CICR response since it has been reported to 
inhibit R-CICR in cardiac muscle [24]. Complete inhibition of 
the R-CICR response was demonstrated at free Ca 2+ concen- 
trations between 10 nM and 300 nM but only 50% inhibition 
was observed between 300 nM and 10/.tM Ca 2+. In contrast, 
the R-CICR response in human vascular smooth muscle cells 
was completely abolished in the presence of ruthenium red over 
the entire range of free Ca -,+ concentrations u ed [20]. These 
results may indicate that one of the isoforms present in myom- 
etrial cells is insensitive to ruthenium red or alternatively, there 
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Fig. 4. The effect of ryanodine on 4SCa2+ release. A: mean data _+ S.E. 
from 9 experiments illustrating the dose response relationship for ryan- 
odine in cultured human myometrial smooth muscle cells. B: a histo- 
gram showing mean data _+ S.E. from 4 paired experiments illustrating 
the effect of ruthenium red and heparin on the ryanodine induced 45Ca :+ 
release from the SR where (A) illustrates the mean control response to 
1/aM ryanodine, (B) and (C) ryanodine-induced r lease in the presence 
of 20/aM ruthenium red and 20/ag/ml heparin, respectively. C: a typical 
experiment (1 of 5) illustrating the effect of 10 mM caffeine on the 
ryanodine dose-response curve. The open bars show control ryanodine 
responses and the filled bars show ryanodine responses in the presence 
of 10 mM caffeine. Ordinates how the mean change in fractional loss 
of 4SCa =+ and abscissa in A and C show the concentration f ryanodine 
in/aM. Temperature of all experiments 22 24°C. 
may be other C ICR responses which are not mediated through 
a ryanodine-sensitive channel [28]. 
In skeletal and cardiac muscle, ryanodine has been used to 
specifically bind to and quantitate the RyR channel. In these 
tissues, the dose response relationship to ryanodine is bell- 
shaped where the RyR channel is locked into a permanently 
open state at concentrat ions <10/aM and at higher concentra- 
tions of ryanodine the channel is blocked [15]. Ryanodine has 
been reported to mobilise Ca z+ from internal stores of intact 
cultured human myometrial  smooth muscle cells and this sensi- 
tivity led to the suggestion that a ryanodine-sensitive Ca> re- 
lease process may be operational [12]. The present data in 
permeabilised cells demonstrates a complex dose response re- 
lationship to ryanodine over the concentrat ion range 0.1 100 
/aM where the cells appear to have two bell-shaped responses. 
This effect is markedly different to the dose response curve 
obtained in vascular smooth muscle cells where there is an 
increase in the ryanodine-induced 4"Ca > release over a similar 
concentrat ion range [20], The significance of these differences 
is unknown at the present time but in myometrial cells the 
presence of two isoforms of the ryanodine receptor channel 
complex may contribute to the complex effects observed with 
ryanodine. The ryanodine-induced 4~Ca> release was sensitive 
to ruthenium red, suggesting that these responses are not a 
non-specific effect of ryanodine but reflect the specific binding 
of ryanodine to the RyR channel. 
It can be concluded from the data reported here that at 
R-CICR mechanism is operational in cultured human myometrial 
smooth muscle cells and that the activation and modulat ion o1" 
this process is complex. It would also appear that although this 
R-CICR process displays some similarity to the R-CICR mech- 
anism described in human vascular smooth muscle cells [2(}], 
there are clear differences in the pharmacological modulat ion 
by various chemical agents. The physiological significance of 
these differences and the molecular mechanisms underlying 
them remain to be determined. 
Acknowledgements' We are grateful to The Wellcome Trust and The 
Physiological Society for financial support. 
References 
[I] Wray, S. (1993) Am. J. Physiol. 264 (Cell Physiol. 33), C1 CI8. 
[2] Berridge, M.J. (1993) Nature 361, 315 325. 
[3] lino, M. (1989) J. Gen. Physiol. 94, 363 383. 
[4] Rousseau, E. and Meissner, G. (I 989i Am. J. Physiol. 256, H328 
H333. 
[5] Somlyo, A.R and Somlyo, A.V. (1994) Nature 372, 231 236. 
[6] Morgan, J.M., Lynn, S., Gillespie, J.l. and Greenwell, J.R. (1993a) 
Exp. Physiol. 78, 711 714. 
[7] Phaneuf. S.. Europe-Firmer, G.N., Varney, M., Mackenzie, I.Z., 
Watson, S.P. and Ldpez-Bernal, A. (1993} J. Endocrinol. 136. 
497 509. 
[8] Gillespie, J.l., Morgan. J.M. and De Smedt, H. (1995)J. Physiol. 
483, 107I". 
[9] Savineau, J.P. and Mironneau, J. (19901 Br. J. Pharnaacol. 99. 
261 266. 
[10] Parker, 1. & Ivorra, I. (1991) J. Physiol. 433, 229 240. 
[11] Toescu, E.C., O'Neill, S.C., Petersen, O.H. and Eisner, D.A. 
(1992} J. Biol. Chem. 267, 23467 23470. 
[12] Lynn, S.. Morgan, J.M., Gillespie. J.l. and Greenwell, J.R. (19931 
FEBS Lett. 330, 227 230. 
[13] MePherson, P.S. and Campbell. K.P. (19931 J. Biol. Chem. 268, 
19765 19790. 
[14] Lu, X., Xu, L. and Meissner, G. ( 1994tJ. Biol. Chem. 269, 6511 6516. 
300 
[15] Coronado, R., Morissette, J., Sukhareva, M. and Vaughan, D.M. 
(1994) Am. J. Physiol. 266, C1485-C1504. 
[16] Hakamata, Y., Nakai, J., Takeshima, H., Imoto, K. (1992) FEBS 
Lett. 312, 29-235. 
[17] Giannini, G., Clementi, E., Ceci, R., Marziali, G. and Sorrentino, 
V. (1992) Science 257, 91-94. 
[18] Gillespie, J.l., Lynn, S., Morgan, J.M., Lamb, H. and Hawkins, 
A. (1994) J. Physiol. 480, 123P. 
[19] Itoh, T., Kuriyama, H. and Suzuki, H. (1981) J. Physiol. 321, 
513-535. 
[20] Lynn, S. and Gillespie, J.I. (1995) FEBS Lett., in press. 
[21] Morgan, J.M., Lynn, S., Gillespie, J.I. and Greenwell, J.R. (1993b) 
Biochem. Biophys. Acta 1158, 98 102. 
J.M. Morgan, J.I. Gillespie/FEBS Letters 369 (1995) 295-300 
[22] Yamamoto, H. and van Breeman, C. (1986) J. Gen. Physiol. 87, 
369-389. 
[23] Smith, G.L. and Miller, D.J. (1984) Biochim. Biophys. Acta 893, 
287-299. 
[24] Smith, J.S., Coronado, R. and Meissner, G. (1985) Nature 316, 
446449. 
[25] Saida, K. and van Breeman, C. (1984) J. Gen. Physiol. 84, 307-318. 
[26] Chen, Q. and van Breeman, C. (1992) Adv. Second Messenger 
Phosphorylation Res. 26, 335 350. 
[27] Anderson, K., Lai, F.A., Liu, Q-Y., Rousseau, E., Erickson, H.P. 
and Meissner, G. (1989) J. Biol. Chem. 264, 1329-1335. 
[28] McNulty, T.J. and Taylor, C.W. (1993) Biochem. J. 291,799 801. 
